Medicare Enrolled
Dr. Steven Sukin, M.D.
Urology Physician · Tomball, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sukin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sukin? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sukin
Dr. Steven Sukin is an urology physician in Tomball, TX, with 20 years in practice. Based on federal Medicare data, Dr. Sukin performed 6,986 Medicare services across 3,363 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sukin received a total of $15,836 from 43 pharmaceutical and/or device companies across 193 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sukin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 15% volume in TX$ $15,836 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,986
Medicare services
Top 15% in TX for urology physician
3,363
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~349 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Leuprolide injectable, camcevi, 1 mg | 1,512 | $65 | $247 |
| Automated urinalysis | 1,470 | $2 | $16 |
| Office visit, established patient (30-39 min) | 1,108 | $84 | $368 |
| Infectious disease DNA/RNA test | 663 | $34 | $166 |
| New patient office visit (45-59 min) | 223 | $109 | $565 |
| Diagnostic exam of bladder and urethra using an endoscope | 203 | $167 | $684 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 163 | $672 | $3,366 |
| Detection test by nucleic acid for organism, quantification | 153 | $42 | $222 |
| Bladder ultrasound after voiding | 135 | $7 | $97 |
| Office visit, established patient (20-29 min) | 125 | $57 | $250 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 96 | $142 | $3,675 |
| Hospital follow-up visit, moderate complexity | 82 | $60 | $247 |
| Initial hospital admission, high complexity | 71 | $123 | $694 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 52 | $25 | $145 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 52 | $16 | $68 |
| Biopsy of prostate gland | 51 | $166 | $775 |
| Ultrasonic guidance for needle placement | 51 | $45 | $633 |
| Yeast/candida DNA test | 51 | $34 | $123 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 51 | $34 | $182 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 51 | $34 | $153 |
| Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 51 | $34 | $153 |
| Detection test by nucleic acid for strep (streptococcus, group a), quantification | 51 | $41 | $146 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 51 | $34 | $123 |
| Simple bladder irrigation and/or instillation | 50 | $52 | $296 |
| Detection test by nucleic acid for chlamydia trachomatis, quantification | 35 | $52 | $187 |
| Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), quantification | 35 | $42 | $150 |
| Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | 35 | $34 | $168 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 30 | $968 | $4,403 |
| Imaging of urinary tract following injection of a contrast agent | 24 | $19 | $61 |
| Electronic assessment of bladder emptying | 23 | $5 | $277 |
| Assessment of muscle signal of pelvic nerves | 23 | $104 | $747 |
| Insertion of device into abdomen with pressure and urine flow rate study | 23 | $147 | $522 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 22 | $295 | $1,205 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 20 | $247 | $837 |
| Shock wave crushing of kidney stones | 19 | $430 | $2,574 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 18 | $302 | $1,272 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 17 | $551 | $3,047 |
| New patient office visit (30-44 min) | 16 | $69 | $372 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | 15 | $210 | $1,670 |
| Detection test for gardnerella vaginalis (bacteria), quantification | 15 | $41 | $146 |
| Repair of vaginal defect using an endoscope | 14 | $335 | $2,685 |
| Surgical repair of vaginal defect using an endoscope | 13 | $756 | $2,872 |
| Injection of biodegradable material next to prostate | 12 | $2,351 | $11,392 |
| Insertion of stent in ureter using an endoscope | 11 | $68 | $2,046 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
3.9% medium
95.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,836
Total received (2018-2024)
Avg $2,262/year across 7 years
Top 14% in TX for urology physician
43
Companies
193
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,328 (90.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,508 (9.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,866
2023$2,153
2022$1,739
2021$367
2020$274
2019$2,966
2018$2,471
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Profound Medical Corp.
$4,721
NeoTract Inc.
$3,231
Boston Scientific Corporation
$1,889
Coloplast Corp
$956
PROCEPT BioRobotics Corporation
$683
Teleflex LLC
$466
Intuitive Surgical, Inc.
$427
Astellas Pharma US Inc
$345
Laborie Medical Technologies Corp.
$248
BOSTON SCIENTIFIC CORPORATION
$229
Myriad Genetic Laboratories, Inc.
$223
ACCORD HEALTHCARE, INC.
$221
Axonics, Inc.
$197
Olympus America Inc.
$187
ABBVIE INC.
$178
INTUITIVE SURGICAL, INC.
$158
Janssen Biotech, Inc.
$152
COLOPLAST CORP
$150
AbbVie Inc.
$138
Palette Life Sciences, Inc.
$125
Allergan Inc.
$112
Ethicon Inc.
$103
TOLMAR Pharmaceuticals, Inc.
$94
PFIZER INC.
$73
NxThera, Inc.
$60
Medtronic, Inc.
$47
Ambu Inc.
$44
Myovant Sciences Inc.
$39
Endo Pharmaceuticals Inc.
$37
UroGen Pharma, Inc.
$35
Antares Pharma, Inc.
$34
ARGON MEDICAL DEVICES, INC.
$32
PALETTE LIFE SCIENCES, INC.
$28
Kowa Pharmaceuticals America, Inc.
$22
Blue Earth Diagnostics Limited
$20
BIOTISSUE HOLDINGS INC.
$19
Telix Pharmaceuticals
$19
AbbVie, Inc.
$19
Ethicon US, LLC
$17
Allergan, Inc.
$16
180 Medical, Inc.
$15
Mission Pharmacal Company
$13
UROVANT SCIENCES INC
$12
Top 3 companies account for 62.1% of total payments
Associated products mentioned in payments ›
ALTIS · AMS · AMS 700 · AMS Ambicor · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · Altis · AquaBeam Robotic System · Axonics · Axumin · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · Clot Management · Da Vinci Surgical System · EDEX · ELIGARD · Erleada · GEMTESA · GENERAL BPH · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · GENERAL - BPH · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · General - Kidney Stone Disease · ILLUCCIX · INTERSTIM · JELMYTO · LITHOVUE · LithoVue · Lupron · Lynx System · MYRBETRIQ · Monarch · NOCDURNA · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · PROLARIS · Porges Coloplast · Restorelle · Rezum · Rezum Generator · SEGLENTIS · SWISS LITHOCLAST TRILOGY · SenSura Mio · SpaceOAR VUE System - 10mL · TACTRA · Tria Firm · Tulsa-Pro · UROLIFT · Uribel · UroLift · UroLift System · VISTASEAL · XIAFLEX · XTANDI · XYOSTED · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $227 per 100 Medicare services performed
Geographic Context
Urology Physicians within 10 mi
62
Per 100K population
1.3
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE TOMBALL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sukin is a clinical cardiology specialist, with above-average Medicare volume (top 15% in TX), and high industry engagement (low-engagement, top 14%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sukin experienced with leuprolide injectable, camcevi, 1 mg?
Based on Medicare claims data, Dr. Sukin performed 1,512 leuprolide injectable, camcevi, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sukin receive payments from pharmaceutical companies?
Yes. Dr. Sukin received a total of $15,836 from 43 companies across 193 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sukin's costs compare to other urology physicians in Tomball?
Dr. Sukin's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sukin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Tomball
Browse urology physicians in Tomball ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Profound Medical Corp. Payments to Doctors
See all physicians who received payments from Profound Medical Corp..
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc..
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology